Comprehensive analysis of tumor immune microenvironment in small cell lung cancer
Not Applicable
- Conditions
- Small cell lung cancer (SCLC)
- Registration Number
- JPRN-UMIN000041056
- Lead Sponsor
- Kindai university, Faculty of Medicine, Department of Medical Oncology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 340
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who never received cytotoxic agents or ICI
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The frequency of SCLC patients characterized by TMB and T-cell inflamed gene expression profile
- Secondary Outcome Measures
Name Time Method The association of the efficacy, OS, PFS, 6 months PFS rate, and ORR of cytotoxic agents as well as ICI and biomarker candidates. The association among biomarker candidates.